Literature DB >> 20586896

Pathophysiological mechanisms contributing to renal dysfunction in chronic heart failure.

Kevin Damman1, Paul R Kalra, Hans Hillege.   

Abstract

Renal dysfunction is extremely common in patients with chronic heart failure (CHF). Although the pathogenesis of reduced glomerular filtration rate (GFR) may differ between patients and even over time within an individual, the result is the same: reduced GFR is strongly related to increased mortality and morbidity. Potential explanations for the renal impairment include shared aetiological risk factors, such as atherosclerosis, hypertension, endothelial dysfunction and inflammation. Furthermore, a complex series of pathophysiological interactions exists between these two organ systems; an abnormality in one system will in general adversely impact on the other, resulting in a vicious cycle of disease progression. Improved understanding of the aetiology of reduced GFR in patients with CHF is fundamental to identifying appropriate therapies. Whilst reduced cardiac output and thereby renal perfusion is undoubtedly important, other factors, such as increased central venous pressure and anaemia may be amenable to therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586896     DOI: 10.1111/j.1755-6686.2010.00172.x

Source DB:  PubMed          Journal:  J Ren Care        ISSN: 1755-6678


  6 in total

1.  VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

Authors:  J Ruth Wu-Wong; Megumi Kawai; Yung-Wu Chen; Masaki Nakane
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure.

Authors:  Frank L Dini; Ryan T Demmer; Anca Simioniuc; Doralisa Morrone; Francesca Donati; Giacinta Guarini; Enrico Orsini; Paolo Caravelli; Mario Marzilli; Paolo C Colombo
Journal:  Eur J Heart Fail       Date:  2012-03       Impact factor: 15.534

3.  The cardiorenal syndrome: making the connection.

Authors:  Gautham Viswanathan; Scott Gilbert
Journal:  Int J Nephrol       Date:  2010-10-04

4.  Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study.

Authors:  Zhi-Qiang Hou; Zhao-Xia Sun; Chong-Yi Su; Hui Tan; Xia Zhong; Bo Hu; Yi Zhou; De-Ya Shang
Journal:  Heart Vessels       Date:  2012-09-23       Impact factor: 2.037

5.  Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction.

Authors:  Nicolas F Schroten; Kevin Damman; Mattia A E Valente; Tom D Smilde; Dirk J van Veldhuisen; Gerjan Navis; Carlo A Gaillard; Adriaan A Voors; Hans L Hillege
Journal:  Clin Res Cardiol       Date:  2015-06-30       Impact factor: 5.460

6.  Association between right ventricle two- and three-dimensional echocardiography and exercise capacity in patients with reduced left ventricular ejection fraction.

Authors:  Aleksandra Sljivic; Milena Pavlovic Kleut; Zoran Bukumiric; Vera Celic
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.